Human Genome Variation (Mar 2024)

End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy

  • Hiroaki Hanafusa,
  • Hiroshi Yamaguchi,
  • Naoya Morisada,
  • Ming Juan YE,
  • Riki Matsumoto,
  • Hiroaki Nagase,
  • Kandai Nozu

DOI
https://doi.org/10.1038/s41439-024-00273-0
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 3

Abstract

Read online

Abstract Autosomal dominant polycystic kidney disease (ADPKD) is commonly caused by PKD1, and mosaic PKD1 variants result in milder phenotypes. We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9. Despite a low-frequency mosaic splicing PKD1 variant, he developed severe renal cysts and end-stage renal disease in his 30 s. This case highlights how environmental factors may contribute to the genetic predisposition to ADPKD.